"Humans do not care about facts. They are moved by stories."
Logic informs. Emotion decides.
Billions are spent every year trying to change how people think and behave. Almost none of it works. We built a company around the one thing that does: a great story, told at scale.
A New Funding Paradigm for Film and TelevisionThe global public health, conservation, and impact investment sector allocates billions annually toward behaviour change. Almost none of it has ever been channelled into premium film and television. CCI is the company that changes that.
Annual global public health communication and behaviour change spend by institutional partners — largely allocated to campaigns that underperform storytelling on every measurable outcome.
More likely to be vaccinated. Children in a narrative intervention vs control. Williams et al, 2026 — JAMA Network Open. Randomised clinical trial.
Peer-reviewed studies across 6 countries demonstrating story-based formats shift vaccine attitudes, confidence, and uptake.
Production companies with a systematic model for accessing this capital. Until now.
Impacttainment
Entertainment where measurable impact is the product, not the byproduct. We partner with institutions whose mandate already funds the story you are telling. The drama is the delivery mechanism. The outcome is the investment thesis.
Broadcaster advances. Gap finance. Presales. Tax credits. Development risk sits entirely with the producer.
Institutional partners are invested in success because success serves their mission. Risk is shared from day one. No broadcaster greenlight required to start.
A Premium Historical Drama Series
"No man has saved more lives in history than a simple country doctor from Gloucestershire."
As smallpox ravages Europe, an unassuming rural physician challenges the medical establishment and a rising tide of fear, propaganda, and early fake news. With a radical idea born from the countryside, Edward Jenner sparks a revolution in science that will ignite global controversy and change the course of human history.
"As misinformation spreads through compelling stories, effective responses must also use story-based approaches rather than facts alone."
VACCA Evidence Appendix, 2026More likely to be vaccinated. Williams et al, 2026 — JAMA. Pilot RCT.
As likely to test for HIV. MTV Shuga viewers vs control, 8 months post-broadcast. World Bank RCT.
Peer-reviewed studies across US, Canada, Philippines, China, India, and Tanzania.
Period drama skews female. Women are the primary vaccination decision-makers for children.
Highest hesitancy countries in Europe are the highest consumers of the period drama genre.
CCI is not inventing the category. We are building the first professional infrastructure to produce it at scale.
Viewers were twice as likely to test for HIV eight months after watching. A drama series, not a PSA. The behaviour shift remained measurable nearly a year post-broadcast.
Long-running multimedia drama that produced population-level improvements in health literacy, social norms, and multiple health behaviours across South Africa.
A radio soap opera that produced a statistically significant increase in family planning adoption. Serialised entertainment changes behaviour at population scale.
Post-release research documented a measurable shift in US public attitudes toward HIV patients. Not a campaign. A film. The mechanism was visible before the science had a name for it.
Each project is a demonstration of the model in practice. The details differ. The logic is consistent.
The man who changed how humanity relates to disease. Premium historical drama. WHO principal partner confirmed. Early development complete.
Moss Side, Manchester. 1990s. One of Britain's most deprived estates. A group of working-class kids discover chess through an unlikable, controversial teacher and smash class barriers in ways no one saw coming. Based on a true story. Life rights secured. Streamer conversations underway, brands attached.
Spanning pharmaceuticals, conservation, military history, alternate history, and renewable energy verticals.
Peter McSweeney
Founder, Creative Director
Filmmaker, writer, and producer. Trained at EAST 15 and Arts Ed. Branded content across pharmaceutical, entertainment, and sports. 18 years building at the intersection of storytelling and business, including roles with RADA and Warner Brothers. Founder of multiple ventures across film, coaching, and live events across three continents.
Erwin Werring
Strategic Advisor, Board Member
Morgan Stanley finance background and pop music writer at Universal Records USA. Serial venture builder across SaaS, web3, and HealthTech. Leads Reducept, a clinically proven VR platform for managing chronic pain without medication.
Philip Langguth
Development & Outreach
Co-founded Mitchell Madison Group, advising Fortune 500 companies on performance and value creation. GM at ING Group for 13 years leading Strategy and M&A. Former McKinsey Associate Principal specialising in financial services, and JP Morgan VP of Product Management. Now advises on scaling, funding, and decentralised economy strategies.
Thomas Buchar
Financial Advisor, Board Member
12 successful exits across media, fintech, DeepTech, and sustainability. CEO of Kultur International Films, behind Riverdance and The Three Tenors. Managing Partner, Global Accelerated Ventures. Oxford University climate compliance partner.
Mark Foligno
Board Member
50+ credits over 30 years. Oscar-winning The King's Speech. BAFTA-winning Moon. Recent credits include Freud's Last Session with Sir Anthony Hopkins and Salvable with Shia LaBeouf. Founder of HYRON AI. SVP at LipSync Post Production.
Rosie Holden
Brand & Marketing Advisor
Former CEO of Havas-owned agency Cake, leading it through rapid growth with clients including Adidas, BAFTA, EE, Arsenal FC, Aston Martin F1, Major League Baseball, and Diageo. Now advises international brands on culture-led marketing, partnerships, and brand strategy.